Influence of impactor operating flow rate on particle size distribution of four jet nebulizers

Yue Zhou, Trevor L. Brasel, Dean Kracko, Yung Sung Cheng, Amitkumar Ahuja, Jeffrey P. Norenberg, H. William Kelly

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

When a nebulizer is evaluated by the Andersen Cascade Impactor (ACI), the flow rate is generally maintained at 28.3 L/min, as recommended by the manufacturer. However, the nebulizer flow rate that a patient inhales is only around 18 L/min. Because the drive flow of a nebulizer is approximately 6-8 L/min, the nebulized drug is mixed with outside air when delivered. Evaluating impactor performance at the 28.3 L/min flow rate is less than ideal because an additional 10 L/min of outside air is mixed with the drug, thereby affecting the drug size distribution and dose before inhalation and deposition in the human lung. In this study we operated the ACI at an 18.0 L/min flow rate to test whether the effect of the changing ambient humidity was being exaggerated by the 28.3 L/min flow rate. The study was carried out at three different relative humidity levels and two different impactor flow rates with four commercially available nebulizers. The mass median aerodynamic diameter (MMAD) and the geometric standard deviation (GSD) of the droplets were found to increase when the impactor was operated at a flow rate of 18 L/min compared to that of 28.3 L/min. The higher MMAD and GSD could cause the patient to inhale less of the drug than expected if the nebulizer was evaluated by the ACI at the operating flow rate of 28.3 L/min.

Original languageEnglish (US)
Pages (from-to)353-359
Number of pages7
JournalPharmaceutical Development and Technology
Volume12
Issue number4
DOIs
StatePublished - Jul 2007
Externally publishedYes

Fingerprint

Nebulizers and Vaporizers
Particle Size
Humidity
Pharmaceutical Preparations
Air
Inhalation
Lung

Keywords

  • Flow rate
  • Impactor
  • Nebulizer

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Zhou, Y., Brasel, T. L., Kracko, D., Cheng, Y. S., Ahuja, A., Norenberg, J. P., & Kelly, H. W. (2007). Influence of impactor operating flow rate on particle size distribution of four jet nebulizers. Pharmaceutical Development and Technology, 12(4), 353-359. https://doi.org/10.1080/10837450701366937

Influence of impactor operating flow rate on particle size distribution of four jet nebulizers. / Zhou, Yue; Brasel, Trevor L.; Kracko, Dean; Cheng, Yung Sung; Ahuja, Amitkumar; Norenberg, Jeffrey P.; Kelly, H. William.

In: Pharmaceutical Development and Technology, Vol. 12, No. 4, 07.2007, p. 353-359.

Research output: Contribution to journalArticle

Zhou, Y, Brasel, TL, Kracko, D, Cheng, YS, Ahuja, A, Norenberg, JP & Kelly, HW 2007, 'Influence of impactor operating flow rate on particle size distribution of four jet nebulizers', Pharmaceutical Development and Technology, vol. 12, no. 4, pp. 353-359. https://doi.org/10.1080/10837450701366937
Zhou, Yue ; Brasel, Trevor L. ; Kracko, Dean ; Cheng, Yung Sung ; Ahuja, Amitkumar ; Norenberg, Jeffrey P. ; Kelly, H. William. / Influence of impactor operating flow rate on particle size distribution of four jet nebulizers. In: Pharmaceutical Development and Technology. 2007 ; Vol. 12, No. 4. pp. 353-359.
@article{c2b699e7702143e28ae5ce77e8a294c6,
title = "Influence of impactor operating flow rate on particle size distribution of four jet nebulizers",
abstract = "When a nebulizer is evaluated by the Andersen Cascade Impactor (ACI), the flow rate is generally maintained at 28.3 L/min, as recommended by the manufacturer. However, the nebulizer flow rate that a patient inhales is only around 18 L/min. Because the drive flow of a nebulizer is approximately 6-8 L/min, the nebulized drug is mixed with outside air when delivered. Evaluating impactor performance at the 28.3 L/min flow rate is less than ideal because an additional 10 L/min of outside air is mixed with the drug, thereby affecting the drug size distribution and dose before inhalation and deposition in the human lung. In this study we operated the ACI at an 18.0 L/min flow rate to test whether the effect of the changing ambient humidity was being exaggerated by the 28.3 L/min flow rate. The study was carried out at three different relative humidity levels and two different impactor flow rates with four commercially available nebulizers. The mass median aerodynamic diameter (MMAD) and the geometric standard deviation (GSD) of the droplets were found to increase when the impactor was operated at a flow rate of 18 L/min compared to that of 28.3 L/min. The higher MMAD and GSD could cause the patient to inhale less of the drug than expected if the nebulizer was evaluated by the ACI at the operating flow rate of 28.3 L/min.",
keywords = "Flow rate, Impactor, Nebulizer",
author = "Yue Zhou and Brasel, {Trevor L.} and Dean Kracko and Cheng, {Yung Sung} and Amitkumar Ahuja and Norenberg, {Jeffrey P.} and Kelly, {H. William}",
year = "2007",
month = "7",
doi = "10.1080/10837450701366937",
language = "English (US)",
volume = "12",
pages = "353--359",
journal = "Pharmaceutical Development and Technology",
issn = "1083-7450",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Influence of impactor operating flow rate on particle size distribution of four jet nebulizers

AU - Zhou, Yue

AU - Brasel, Trevor L.

AU - Kracko, Dean

AU - Cheng, Yung Sung

AU - Ahuja, Amitkumar

AU - Norenberg, Jeffrey P.

AU - Kelly, H. William

PY - 2007/7

Y1 - 2007/7

N2 - When a nebulizer is evaluated by the Andersen Cascade Impactor (ACI), the flow rate is generally maintained at 28.3 L/min, as recommended by the manufacturer. However, the nebulizer flow rate that a patient inhales is only around 18 L/min. Because the drive flow of a nebulizer is approximately 6-8 L/min, the nebulized drug is mixed with outside air when delivered. Evaluating impactor performance at the 28.3 L/min flow rate is less than ideal because an additional 10 L/min of outside air is mixed with the drug, thereby affecting the drug size distribution and dose before inhalation and deposition in the human lung. In this study we operated the ACI at an 18.0 L/min flow rate to test whether the effect of the changing ambient humidity was being exaggerated by the 28.3 L/min flow rate. The study was carried out at three different relative humidity levels and two different impactor flow rates with four commercially available nebulizers. The mass median aerodynamic diameter (MMAD) and the geometric standard deviation (GSD) of the droplets were found to increase when the impactor was operated at a flow rate of 18 L/min compared to that of 28.3 L/min. The higher MMAD and GSD could cause the patient to inhale less of the drug than expected if the nebulizer was evaluated by the ACI at the operating flow rate of 28.3 L/min.

AB - When a nebulizer is evaluated by the Andersen Cascade Impactor (ACI), the flow rate is generally maintained at 28.3 L/min, as recommended by the manufacturer. However, the nebulizer flow rate that a patient inhales is only around 18 L/min. Because the drive flow of a nebulizer is approximately 6-8 L/min, the nebulized drug is mixed with outside air when delivered. Evaluating impactor performance at the 28.3 L/min flow rate is less than ideal because an additional 10 L/min of outside air is mixed with the drug, thereby affecting the drug size distribution and dose before inhalation and deposition in the human lung. In this study we operated the ACI at an 18.0 L/min flow rate to test whether the effect of the changing ambient humidity was being exaggerated by the 28.3 L/min flow rate. The study was carried out at three different relative humidity levels and two different impactor flow rates with four commercially available nebulizers. The mass median aerodynamic diameter (MMAD) and the geometric standard deviation (GSD) of the droplets were found to increase when the impactor was operated at a flow rate of 18 L/min compared to that of 28.3 L/min. The higher MMAD and GSD could cause the patient to inhale less of the drug than expected if the nebulizer was evaluated by the ACI at the operating flow rate of 28.3 L/min.

KW - Flow rate

KW - Impactor

KW - Nebulizer

UR - http://www.scopus.com/inward/record.url?scp=34548363463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548363463&partnerID=8YFLogxK

U2 - 10.1080/10837450701366937

DO - 10.1080/10837450701366937

M3 - Article

C2 - 17763140

AN - SCOPUS:34548363463

VL - 12

SP - 353

EP - 359

JO - Pharmaceutical Development and Technology

JF - Pharmaceutical Development and Technology

SN - 1083-7450

IS - 4

ER -